心脉医疗
(688016)
| 流通市值：117.73亿 | | | 总市值：117.73亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 332,189,385.86 | 1,206,326,728.85 | 969,564,236.7 | 787,174,656.18 |
| 营业收入 | 332,189,385.86 | 1,206,326,728.85 | 969,564,236.7 | 787,174,656.18 |
| 二、营业总成本 | 183,356,645.13 | 663,428,424.66 | 443,293,120.87 | 323,455,886.28 |
| 营业成本 | 100,944,833.74 | 325,577,170.52 | 237,583,526.66 | 184,417,127.73 |
| 税金及附加 | 3,463,866.56 | 10,477,237.42 | 8,728,749.79 | 8,236,853.67 |
| 销售费用 | 44,684,383.34 | 156,846,814.45 | 92,308,589.63 | 62,389,783 |
| 管理费用 | 20,228,541.7 | 93,405,838.97 | 45,472,931.03 | 28,319,058.82 |
| 研发费用 | 15,941,366.59 | 93,769,544.44 | 71,250,689.15 | 48,673,142.99 |
| 财务费用 | -1,906,346.8 | -16,648,181.14 | -12,051,365.39 | -8,580,079.93 |
| 其中:利息费用 | 951,200.99 | 1,648,780.8 | 1,155,169.67 | 832,596.11 |
| 其中:利息收入 | 3,157,648.33 | 17,090,466.76 | 13,545,716.85 | 9,266,687.77 |
| 加:投资收益 | 4,226,177.26 | 87,410,584.23 | 79,578,889.01 | 16,457,857.09 |
| 资产处置收益 | - | 25,522.26 | - | - |
| 资产减值损失(新) | -1,263,238.02 | -4,689,643.46 | -3,773,317.77 | -2,101,578.71 |
| 信用减值损失(新) | -5,472,001.31 | -3,246,874.58 | -3,210,007.36 | -10,025,162.37 |
| 其他收益 | 4,547,610.03 | 38,774,540.21 | 38,923,557.36 | 4,691,353.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 150,871,288.69 | 661,172,432.85 | 637,790,237.07 | 472,741,239.67 |
| 加:营业外收入 | 172.02 | 59,548.78 | 61,575.07 | 61,475.06 |
| 减:营业外支出 | 5,877.21 | 9,038,063.29 | 1,622,406.33 | 1,647,476.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 150,865,583.5 | 652,193,918.34 | 636,229,405.81 | 471,155,238.14 |
| 减:所得税费用 | 22,869,874.62 | 159,445,587.35 | 89,052,238.3 | 71,574,584.17 |
| 六、净利润 | 127,995,708.88 | 492,748,330.99 | 547,177,167.51 | 399,580,653.97 |
| 持续经营净利润 | 127,995,708.88 | 492,748,330.99 | 547,177,167.51 | 399,580,653.97 |
| 归属于母公司股东的净利润 | 129,636,898.33 | 502,100,205.69 | 553,338,118.91 | 403,523,612.05 |
| 少数股东损益 | -1,641,189.45 | -9,351,874.7 | -6,160,951.4 | -3,942,958.08 |
| (一)基本每股收益 | 1.05 | 4.07 | 4.49 | 3.27 |
| (二)稀释每股收益 | 1.05 | 4.07 | 4.49 | 3.27 |
| 八、其他综合收益 | -3,262,364.66 | -15,299,903.88 | -7,150,817.73 | 57,363.55 |
| 归属于母公司股东的其他综合收益 | -3,262,364.66 | -15,299,903.88 | -7,150,817.73 | 57,363.55 |
| 九、综合收益总额 | 124,733,344.22 | 477,448,427.11 | 540,026,349.78 | 399,638,017.52 |
| 归属于母公司股东的综合收益总额 | 126,374,533.67 | 486,800,301.81 | 546,187,301.18 | 403,580,975.6 |
| 归属于少数股东的综合收益总额 | -1,641,189.45 | -9,351,874.7 | -6,160,951.4 | -3,942,958.08 |
| 公告日期 | 2025-04-30 | 2025-03-29 | 2024-10-30 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |